UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 108

Sortiert nach

Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response

Leukemia, 2017-12, Vol.31 (12), p.2761-2770

2017

Link zum Volltext

Verfügbarkeit prüfen

Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALL

Leukemia, 2022-04, Vol.36 (4), p.901-912

2022

Link zum Volltext

Verfügbarkeit prüfen

Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells

Leukemia, 2012-08, Vol.26 (8), p.1752-1760

2012

Link zum Volltext

Verfügbarkeit prüfen

Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia

Leukemia, 2019-10, Vol.33 (10), p.2365-2378

2019

Link zum Volltext

Verfügbarkeit prüfen

The complete evaluation of erythrocytosis: congenital and acquired

Leukemia, 2009-05, Vol.23 (5), p.834-844

2009

Link zum Volltext

Verfügbarkeit prüfen

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells

Leukemia, 2012-02, Vol.26 (2), p.255-264

2012

Link zum Volltext

Verfügbarkeit prüfen

Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia

Leukemia, 2007-11, Vol.21 (11), p.2240-2245

2007

Link zum Volltext

Verfügbarkeit prüfen

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Leukemia, 2015-05, Vol.29 (5), p.1104-1114

2015

Link zum Volltext

Verfügbarkeit prüfen

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Leukemia, 2007-08, Vol.21 (8), p.1700-1707

2007

Link zum Volltext

Verfügbarkeit prüfen

Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report

Leukemia, 2014-06, Vol.28 (6), p.1235-1241

2014

Link zum Volltext

Verfügbarkeit prüfen

Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo

Leukemia, 2009-09, Vol.23 (9), p.1650-1657

2009

Link zum Volltext

Verfügbarkeit prüfen

Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma

Leukemia, 2007-12, Vol.21 (12), p.2519-2526

2007

Link zum Volltext

Verfügbarkeit prüfen

Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity

Leukemia, 2007-10, Vol.21 (10), p.2117-2127

2007

Link zum Volltext

Verfügbarkeit prüfen

Hunting for clinical translation with innate-like immune cells and their receptors

Leukemia, 2014-06, Vol.28 (6), p.1181-1190

2014

Link zum Volltext

Verfügbarkeit prüfen

Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia

Leukemia, 2014-11, Vol.28 (11), p.2165-2177

2014

Link zum Volltext

Verfügbarkeit prüfen

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

Leukemia, 2012-10, Vol.26 (10), p.2277-2285

2012

Link zum Volltext

Verfügbarkeit prüfen

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma

Leukemia, 2006-10, Vol.20 (10), p.1863-1869

2006

Link zum Volltext

Verfügbarkeit prüfen

Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo

Leukemia, 2004-12, Vol.18 (12), p.1951-1963

2004

Link zum Volltext

Verfügbarkeit prüfen

Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL

Leukemia, 2013-02, Vol.27 (2), p.305-314

2013

Link zum Volltext

Verfügbarkeit prüfen

Compensatory PI3-kinase Akt mTor activation regulates imatinib resistance development

Leukemia, 2005-10, Vol.19 (10), p.1774-1782

2005

Link zum Volltext

Verfügbarkeit prüfen

A pilot pharmacokinetic study of oral azacitidine

Leukemia, 2008-09, Vol.22 (9), p.1680-1684

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma

Leukemia, 2009-10, Vol.23 (10), p.1867-1874

2009

Link zum Volltext

Verfügbarkeit prüfen

Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases

Leukemia, 2002-03, Vol.16 (3), p.299-305

2002

Link zum Volltext

Verfügbarkeit prüfen

CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells

Leukemia, 2005-12, Vol.19 (12), p.2296-2303

2005

Link zum Volltext

Verfügbarkeit prüfen

26 – 50 von 108

Suche als RSS-Feed

Aktive Filter

KollektionScienceDirect Journals

KollektionNexis Uni

Zeitschrift / SerieLeukemia

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(108)
Mit Volltextzugriff
(108)

Publikationsform

Artikel
(108)

Sprache

Englisch
(108)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Hematology
(104)
Life Sciences & Biomedicine
(104)
Oncology
(104)
Science & Technology
(104)
Humans
(101)
Leukemia
(75)
Biological And Medical Sciences
(60)
Medical Sciences
(57)
Animals
(49)
Hematologic And Hematopoietic Diseases
(45)
Genetic Aspects
(44)
Mice
(43)
Apoptosis
(34)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(32)
Care And Treatment
(31)
Female
(31)
Health Aspects
(31)
Bone Marrow
(30)
Myeloid Leukemia
(29)
Cancer Research
(24)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB Free E-Journals
(108)
Nature
(108)
WK Lippincott Williams & Wilkins–Connect here FIRST to enable access
(106)
MEDLINE
(105)
Ingenta
(33)
IngentaConnect Journals
(2)

1 weiteren anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Leu Kemia
(1)
Molecular Plant-Microbe Interactions
(1)

Menü

Weitere Dienste

Einstellungen

Targeting HDAC3, a new partner protein of AKT in the reversal of chemoresistance in acute myeloid leukemia via DNA damage response

Synergistic activity of combined inhibition of anti-apoptotic molecules in B-cell precursor ALL

Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells

Blocking ATM-dependent NF-κB pathway overcomes niche protection and improves chemotherapy response in acute lymphoblastic leukemia

HDAC1,2 inhibition and doxorubicin impair Mre11-dependent DNA repair and DISC to override BCR-ABL1-driven DSB repair in Philadelphia chromosome-positive B-cell precursor acute lymphoblastic leukemia

The complete evaluation of erythrocytosis: congenital and acquired

The novel calicheamicin-conjugated CD22 antibody inotuzumab ozogamicin (CMC-544) effectively kills primary pediatric acute lymphoblastic leukemia cells

Therapeutic potential of CD22-specific antibody-targeted chemotherapy using inotuzumab ozogamicin (CMC-544) for the treatment of acute lymphoblastic leukemia

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Aberrant marker expression patterns on the CD34+CD38− stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission

Excess congenital non-synonymous variation in leukemia-associated genes in MLL- infant leukemia: a Children's Oncology Group report

Enhanced expression of FHL2 leads to abnormal myelopoiesis in vivo

Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma

Trolox enhances the anti-lymphoma effects of arsenic trioxide, while protecting against liver toxicity

Hunting for clinical translation with innate-like immune cells and their receptors

Low expression of Abelson interactor-1 is linked to acquired drug resistance in Bcr-Abl-induced leukemia

E2F4 plays a key role in Burkitt lymphoma tumorigenesis

Thymoglobulin targets multiple plasma cell antigens and has in vitro and in vivo activity in multiple myeloma

Histone deacetylase inhibitor NVP-LAQ824 has significant activity against myeloid leukemia cells in vitro and in vivo

Receptor kinase profiles identify a rationale for multitarget kinase inhibition in immature T-ALL

Compensatory PI3-kinase Akt mTor activation regulates imatinib resistance development

A pilot pharmacokinetic study of oral azacitidine

Targeting the mammalian target of Rapamycin to inhibit VEGF and cytokines for the treatment of primary effusion lymphoma

Antiproliferative effect of plant cytokinin analogues with an inhibitory activity on cyclin-dependent kinases

CD44 ligation induces apoptosis via caspase- and serine protease-dependent pathways in acute promyelocytic leukemia cells

Aktive Filter

Suchergebnisse filtern